Latest Sick sinus syndrome Stories
Two important studies were released at the Late Breaking Clinical Trials session II at EHRA EUROPACE 2013.
Many heart patients in India are too poor to afford pacemakers.
REYKJAVIK, Iceland, March 6, 2011 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics and academic colleagues from Iceland, The Netherlands, Denmark, USA and Illumina, Inc., today report the discovery of single-letter variants (SNPs) in the sequence of the human genome associated with high risk of sick sinus syndrome (SSS).
In the news release, New Trial Studies Link Between Stroke and Atrial Fibrillation, issued 07-Dec-2010 by Northwestern Memorial Hospital over PR Newswire, we are advised by the organization that the 11th paragraph, first sentence, should read "If we can monitor more cryptogenic stroke patients for atrial fibrillation beyond the standard time frame..." rather than "...beyond the standard month..." as originally issued inadvertently.
Scientists at The University of Manchester have solved a mystery connected with why people die from sudden cardiac arrest during sleep â€“ potentially saving thousands of lives.
PARIS, May 12, 2010 /PRNewswire-FirstCall/ -- - New Outcomes Trial to Expand Evidence for Dronedarone in a Different AF Population Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the initiation of a multinational, randomized double-blind Phase IIIb trial, PALLAS, to assess the potential clinical benefit of Multaq(R) (dronedarone) in over 10, 000 patients with permanent atrial fibrillation (AF) to reduce major adverse cardiovascular events.
BRIDGEWATER, N.J., July 28 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that MULTAQ((R)) (dronedarone) 400 mg Tablets is now available in pharmacies in the United States.
- An armed gangster.